Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Triple Negative Metastatic Breast Cancer|BRCA-mutated Solid Tumor
Interventions: DRUG: BMN-673|DRUG: Carboplatin|DRUG: Paclitaxel
Sponsor: Pamela Munster
Collaborators: QuantumLeap Healthcare Collaborative